Comparison of treatment response, survival and safety between drug-eluting bead transarterial chemoembolization with CalliSpheres ® microspheres versus conventional transarterial chemoembolization in treating hepatocellular carcinoma.
CONCLUSIONS: The short-term CR and ORR of DEB-TACE treatment with CSM are better, while OS, DFS and safety were equivalent compared to cTACE in treating HCC patients.
PMID: 31424674 [PubMed - in process]
Source: Journal of B.U.ON. - Category: Cancer & Oncology Tags: J BUON Source Type: research
More News: Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Liver | Liver Cancer | Pain | Study | Urology & Nephrology